Solesence

SLSN · NASDAQ

$0.90+$0.0073 (+0.82%)TodayMarket closed ·
Prev close $0.8927

Latest news

  • News

    Solesence Reports Q2 2026 Results: Full Earnings Call Transcript

  • Press releaseGlobe Newswire

    Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards

  • News

    Solesence Reports Q1 2026 Results: Full Earnings Call Transcript

  • News

    Earnings Scheduled For May 12, 2026

  • Press releaseGlobe Newswire

    Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

  • News

    Earnings Scheduled For March 31, 2026

  • News

    11 Materials Stocks Moving In Thursday's Intraday Session

  • News

    Solesence Q3 EPS $(0.02) Down From $0.04 YoY, Sales $14.597M Down From $16.866M YoY

  • Press releaseGlobe Newswire

    Solésence Reports Third Quarter 2025 Financial Results

  • News

    Earnings Scheduled For November 11, 2025

  • Press releaseGlobe Newswire

    Solésence, Inc. Appoints Yoana Dvorzsak as Vice President of Innovation and Product Integrity

  • News

    Solesence Q2 EPS $0.04, Sales $20.26M

  • News

    Earnings Scheduled For July 31, 2025

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.